Henrik Rammer

Henrik Rammer is an experienced board member and investor with a diverse background in the medical device and finance sectors. Currently serving on the boards of MYoroface AB and Chordate Medical AB, Rammer has a focus on innovative healthcare solutions, including treatments for orofacial disorders and neuromodulation for migraine relief. Previous roles include board positions at AddBio AB, SensAbues, and Paradiset, as well as co-founding RRM Capital Partners. Rammer has held influential positions at Axcel and Triton Partners, specializing in investment strategies, and was a co-founder and CFO of Allocation Network GmbH. Rammer holds a Bachelor of Science degree in Economics from The London School of Economics and Political Science and a Baccalauréat in Economics from Lycée Albert 1er in Monaco.